Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-11-07 Sale |
2023-11-08 4:22 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer |
382 | $12.65 | $4,832 | 124,511 (Direct) |
View |
| 2023-09-01 Sale |
2023-09-05 4:23 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer |
273 | $21.82 | $5,956 | 124,893 (Direct) |
View |
| 2023-03-03 Sale |
2023-03-07 4:52 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer |
21,421 | $76.16 | $1,631,411 | 124,799 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 4:41 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer |
937 | $75.28 | $70,535 | 146,220 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-02 5:00 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer |
1,923 | $76.36 | $146,845 | 131,666 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-09 6:20 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
387 | $108 | $41,796 | 82,843 (Direct) |
View |
| 2022-09-02 Sale |
2022-09-06 5:12 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
269 | $79.04 | $21,261 | 83,230 (Direct) |
View |
| 2022-03-09 Sale |
2022-03-11 4:54 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
3,669 | $71.19 | $261,196 | 86,904 (Direct) |
View |
| 2022-03-07 Sale |
2022-03-09 4:56 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
7,775 | $69.73 | $542,116 | 81,908 (Direct) |
View |
| 2022-03-03 Sale |
2022-03-07 6:23 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
5,543 | $72.54 | $402,064 | 133,941 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-07 4:32 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
657 | $138.57 | $91,041 | 73,512 (Direct) |
View |
| 2021-08-04 Sale |
2021-08-06 4:41 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
2,063 | $148.71 | $306,789 | 74,169 (Direct) |
View |
| 2021-08-03 Sale |
2021-08-04 5:09 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
1,654 | $149.43 | $247,157 | 76,232 (Direct) |
View |
| 2021-06-10 Sale |
2021-06-11 4:26 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
23,540 | $215 | $5,061,100 | 77,732 (Direct) |
View |
| 2021-05-05 Sale |
2021-05-06 4:17 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
1,290 | $199.67 | $257,574 | 101,272 (Direct) |
View |
| 2021-05-04 Sale |
2021-05-05 4:09 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
1,043 | $200.86 | $209,493 | 102,562 (Direct) |
View |
| 2021-03-05 Sale |
2021-03-09 4:17 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
4,550 | $131.53 | $598,462 | 107,423 (Direct) |
View |
| 2020-09-09 Sale |
2020-09-11 4:19 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
28,321 | $85.41 | $2,418,881 | 70,465 (Direct) |
View |
| 2020-09-02 Sale(A) |
2020-09-11 4:13 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
4,200 | $85.01 | $357,054 | 98,786 (Direct) |
View |
| 2020-09-02 Purchase |
2020-09-03 4:37 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
4,200 | $85.01 | $357,054 | 102,565 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 4:13 pm |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
3,717 | $76.63 | $284,828 | 101,018 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-30 Option Award |
2023-07-06 4:14 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer |
367 | $35.28 | 125,166 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-06 4:41 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer |
47,182 | $0 | 146,220 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 5:00 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer |
19,055 | $0 | 131,666 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 5:00 pm |
2024-02-28 2033-02-27 |
NovoCure Ltd | NVCR | Shah Pritesh Chief Growth Officer |
31,691 | $76.97 | 131,666 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-07 5:45 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
312 | $59.08 | 83,499 (Direct) |
View |
| 2021-07-31 Exercise |
2022-03-11 4:54 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
3,717 | $154.01 | 86,904 (Direct) |
View |
| 2021-07-31 Exercise |
2022-03-11 4:54 pm |
2021-07-31 N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
3,717 | $0 | 86,904 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:23 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
21,714 | $0 | 133,941 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:23 pm |
2023-03-01 2032-02-29 |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
44,258 | $80.59 | 133,941 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 5:29 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
154 | $137.12 | 77,886 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-05 4:09 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
2,333 | $204.1 | 102,562 (Direct) |
View |
| 2021-05-03 Exercise |
2021-05-05 4:09 pm |
2021-05-01 N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
2,333 | $0 | 102,562 (Direct) |
View |
| 2021-03-05 Exercise |
2021-03-09 4:17 pm |
N/A 2027-02-21 |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
13,987 | $0 | 107,423 (Direct) |
View |
| 2021-03-05 Exercise |
2021-03-09 4:17 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
13,987 | $7.15 | 107,423 (Direct) |
View |
| 2021-03-02 Option Award |
2021-03-04 5:46 pm |
N/A 2031-03-01 |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
30,890 | $0 | 122,822 (Direct) |
View |
| 2021-02-27 Exercise |
2021-03-02 4:18 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
3,086 | $149.1 | 92,844 (Direct) |
View |
| 2021-02-27 Exercise |
2021-03-02 4:18 pm |
2021-02-27 N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
3,086 | $0 | 92,844 (Direct) |
View |
| 2020-10-29 Exercise |
2020-10-30 4:08 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
10,037 | $11.46 | 89,758 (Direct) |
View |
| 2020-10-29 Exercise |
2020-10-30 4:08 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
14,518 | $7.48 | 89,758 (Direct) |
View |
| 2020-10-29 Exercise |
2020-10-30 4:08 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
5,913 | $14.37 | 89,758 (Direct) |
View |
| 2020-10-29 Exercise |
2020-10-30 4:08 pm |
N/A 2024-02-25 |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
30,468 | $0 | 89,758 (Direct) |
View |
| 2020-09-01 Option Award |
2020-09-03 4:37 pm |
N/A 2030-08-31 |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
5,747 | $0 | 102,565 (Direct) |
View |
| 2020-07-31 Exercise |
2020-08-03 5:39 pm |
2020-07-31 N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
3,717 | $0 | 108,452 (Direct) |
View |
| 2020-07-31 Exercise |
2020-08-03 5:39 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
3,717 | $76.17 | 108,452 (Direct) |
View |
| 2020-07-07 Option Award |
2020-07-08 4:25 pm |
N/A N/A |
NovoCure Ltd | NVCR | Shah Pritesh Chief Commercial Officer |
325 | $50.41 | 101,018 (Direct) |
View |